We Are Unique, Llc in Goulds, FL - Behavior Analyst

We Are Unique, Llc is a mental health clinic (Behavior Analyst) in Goulds, Florida. The current practice location for We Are Unique, Llc is 11276 Sw 232nd St, Goulds, Florida. For appointments, you can reach them via phone at (786) 286-1644. The mailing address for We Are Unique, Llc is 11276 Sw 232nd St, Goulds, Florida and phone number is (786) 286-1644.

We Are Unique, Llc is licensed to practice in Florida (license number B630117891680) and its NPI number is 1477088946. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (786) 286-1644.

Contact Information

	We Are Unique, Llc
	11276 Sw 232nd St Goulds FL 33170-7505
	(786) 286-1644
	Not Available

Mental Health Clinic Profile

Full Name	We Are Unique, Llc
Speciality	Behavior Analyst
Location	11276 Sw 232nd St, Goulds, Florida
Authorized Official Name and Position	Christian Steven Brito (OWNER)
Authorized Official Contact	7862861644
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
We Are Unique, Llc 11276 Sw 232nd St Goulds FL 33170-7505 Ph: (786) 286-1644	We Are Unique, Llc 11276 Sw 232nd St Goulds FL 33170-7505 Ph: (786) 286-1644

NPI Details:

NPI Number	1477088946
Provider Enumeration Date	04/21/2017
Last Update Date	02/13/2020
Certification Date	02/13/2020

Medical Identifiers

Medical identifiers for We Are Unique, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477088946	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103K00000X	Behavior Analyst	B630117891680 (Florida)	Primary
106E00000X	Assistant Behavior Analyst	(* (Not Available))	Secondary
106S00000X	Behavior Technician	(* (Not Available))	Secondary

News Archive

First COVID-19-related clinical trial to start in Germany

German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.

Emotional response of persons linked to series of television adverts

What effect does a TV advert have on a viewer? How does it bring about a change in their knowledge, emotions or intentions? These questions have existed alongside advertising ever since it began. Through a psycho-physiological study developed jointly by El Bureau de la Comunicaci-n, the Tecnalia Centre for Applied Research, and the UPV/EHU, it has been possible to measure the emotional response of a person to a series of television adverts.

Advanced optical measures may help predict change in visual acuity, study says

Sophisticated new optical quality metrics can identify older adults likely to have more rapid age-related declines in vision, suggests a study, "Factors Accounting for the 4-Year Change in Acuity in Patients Between 50 and 80 Years", in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Expert questions validity of genetic testing patents

Molecular Pathologist-Attorney Roger D. Klein in a letter published in the February 15, 2007 issue of the New England Journal of Medicine questioned the validity of patents often used to prevent clinical laboratories from performing certain genetic tests.

We Are Unique, Llc - Mental Health Clinic in Goulds, FL